merck

Blockchain in Pharma Unleashes a New Era of Trust and Efficiency – ET HealthWorld

by
Blockchain in Pharma Unleashes a New Era of Trust and Efficiency – ET HealthWorld

In the ever-evolving landscape of pharmaceuticals, where precision, safety, and trust are non-negotiable, blockchain technology emerges as the beacon of a revolutionary transformation. Beyond its cryptocurrency origins, blockchain is poised to redefine lifescience businesses, reshaping processes from the laboratory to the global supply chain. As per a Gartner report, blockchain’s business value in the pharmaceutical … Read more

Biotech AI startup Unlearn adds $15 million and OpenAI CTO to board – ET HealthWorld

by
Biotech AI startup Unlearn adds million and OpenAI CTO to board – ET HealthWorld

Bengaluru: Unlearn.AI, which has built a machine learning platform that creates “digital twin” profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate regulatory approval, the company told Reuters on Tuesday. The investment from Radical Ventures and Wittington Ventures valued the startup at $265 million, the company said. Mira Murati, … Read more

European Union’s drug regulator green lights Pfizer’s COVID-19 pill

by
European Union’s drug regulator green lights Pfizer’s COVID-19 pill

The European Union’s drug regulator on Thursday conditionally approved the use of Pfizer Inc’s antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant. The endorsement by the European Medicines Agency (EMA) allows EU member states to deploy the drug after … Read more

FDA OKs Emergency Use of Merck Pill for COVID-19

by
FDA OKs Emergency Use of Merck Pill for COVID-19

Dec. 23, 2021 — The FDA has granted emergency use authorization to Merck’s antiviral drug to treat adults with mild to moderate COVID-19 who are at risk for severe disease. Similar to FDA authorization of another antiviral pill regimen — ritonavir plus nirmatrelvir, or Paxlovid — granted to Pfizer on Wednesday, molnupiravir (brand name Lagevrio) … Read more

Merck’s COVID-19 Pill May Be Less Effective Than First Hoped

by
Merck’s COVID-19 Pill May Be Less Effective Than First Hoped

Nov. 29, 2021 — Merck’s antiviral pill for COVID-19, molnupiravir, appears to be far less effective than early results from the clinical trial first suggested. According to an analysis by scientists at the FDA, the experimental pill cut the risk of hospitalization or death from COVID-19 by about 30%, compared to a placebo, and the … Read more

Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID

by
Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID

Robin Foster, HealthDay Reporter FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection … Read more

Covid-19 pandemic has demonstrated importance of diagnostics and R&D in fighting pandemics: Country Speaker & Head of Research Solutions Commercial, Merck

by
Covid-19 pandemic has demonstrated importance of diagnostics and R&D in fighting pandemics: Country Speaker & Head of Research Solutions Commercial, Merck

Sunil Punjabi, Country Speaker & Head of Research Solutions Commercial, Merck In the Budget 2021-22 the govt of India has given more focus on health sector as the Covid-19 pandemic is not over. Manufacturing and distribution of vaccines continues to be a key priority in 2021. Infectious disease research and early-stage disease management are critical … Read more